Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Rejects “Approvable” And “Not Approvable” Letters
09 Jul 2008
•
By
Cathy Dombrowski
Agency will begin Aug. 11 to use “complete response” letters instead.
More from Archive
More from Pink Sheet